R1	AND Arg1:T1 Arg2:T2	
R2	AND Arg1:T4 Arg2:T5	
R3	AND Arg1:T8 Arg2:T9	
R4	AND Arg1:T7 Arg2:T8	
R5	Has_temporal Arg1:T4 Arg2:T6	
*	OR T4 T10
R6	Subsumes Arg1:T10 Arg2:T7	
*	OR T12 T13
R7	AND Arg1:T11 Arg2:T12	
R8	Has_value Arg1:T15 Arg2:T16	
R9	Has_value Arg1:T19 Arg2:T20	
R10	Has_value Arg1:T17 Arg2:T18	
R11	Has_value Arg1:T21 Arg2:T22	
R12	Has_value Arg1:T24 Arg2:T25	
R13	Has_qualifier Arg1:T22 Arg2:T23	
R14	Has_qualifier Arg1:T25 Arg2:T26	
R15	Has_value Arg1:T27 Arg2:T28	
R16	Has_value Arg1:T29 Arg2:T30	
R17	AND Arg1:T31 Arg2:T32	
R18	AND Arg1:T31 Arg2:T34	
R19	AND Arg1:T34 Arg2:T33	
R20	Has_value Arg1:T35 Arg2:T36	
R21	Has_value Arg1:T41 Arg2:T42	
*	OR T43 T44
*	OR T45 T46
T1	Condition 0 14	Non-compliance
T2	Procedure 20 27	DOTPlus
T3	Non-query-able 29 202	Alternatively DOT can be done by telephoning patient on a daily basis 5 times a week and having patient annotate taking drug in a log which would be reviewed by clinic staff
T4	Procedure 221 228	treated
T5	Condition 233 245	tuberculosis
T6	Temporal 246 266	in the prior 2 years
T7	Procedure 298 309	PCR testing
T8	Condition 319 330	sensitivity
T9	Drug 334 343	rifamycin
T10	Condition 283 286	DST
T11	Condition 352 368	hypersensitivity
T12	Drug 372 380	rifampin
T13	Drug 384 393	rifabutin
T15	Measurement 396 409	Liver enzymes
T16	Value 410 434	greater than 2 times ULN
T17	Measurement 437 446	Bilirubin
T18	Value 447 471	greater than 2 times ULN
T19	Measurement 474 490	Serum creatinine
T20	Value 491 515	greater than 3 times ULN
T21	Measurement 518 528	Hemoglobin
T22	Value 529 546	less than 7.0 gms
T23	Qualifier 547 579	even if receiving erythropoietin
T24	Measurement 582 607	Absolute neutrophil count
T25	Value 608 631	less than 750 cells/mm3
T26	Qualifier 632 655	even if receiving G-CSF
T27	Measurement 658 679	Fasting triglycerides
T28	Value 680 702	greater than 400 mg/dL
T29	Measurement 705 724	Fasting cholesterol
T30	Value 725 753	> 1.6 upper limits of normal
T31	Condition 756 770	GI intolerance
T32	Drug 774 798	tuberculosis medications
T33	Drug 828 852	tuberculosis medications
T34	Procedure 809 824	discontinuation
T35	Measurement 855 870	Fasting glucose
T36	Value 871 888	greater 150 mg/dL
T37	Condition 891 899	Pregnant
T38	Person 900 905	women
T39	Post-eligibility 908 948	Use of one of the prohibited medications
T40	Post-eligibility 950 1043	Any condition that the investigators feel could compromise the use of the current medication.
T41	Measurement 1052 1066	CD4 cell count
T42	Value 1070 1089	50 cells/mm3or less
T43	Condition 1091 1102	Hepatitis B
T44	Condition 1091 1100;1106 1107	Hepatitis C
T45	Observation 1119 1126;1143 1146	Alcohol use
T46	Observation 1130 1146	illicit drug use
